Literature DB >> 9578128

ABR and temporal bone pathology in Hurler's disease.

Y Komura1, K Kaga, Y Ogawa, Y Yamaguchi, T Tsuzuku, J I Suzuki.   

Abstract

This is believed to be the first report on estimating hearing loss in Hurler's disease, based on the correlation between ABR and temporal bone pathology. ABR findings revealed hearing loss to be about 70 dB or more as result of peripheral mixed impairment. A histological study of the temporal bones revealed almost all pathological findings in the conductive system, except for the hyperplastic arachnoid in the internal auditory canal. In the middle ear cavity, otitis media, residual mesenchyme and deformity of ossicles were found. We explain the conductive component to be due to otitis media and poor ossicular connection. However, the etiology of the sensorineural component remains speculative. In Hurler's disease, hearing loss with mental retardation is often found at infantile age. Therefore, assessing the extent of hearing loss exactly was difficult, for example, the severity. the etiology and incidence of sensorineural impairment. We emphasize the need for not only well-described pathological studies but also for more objective functional investigations, at least ABR.

Entities:  

Mesh:

Year:  1998        PMID: 9578128     DOI: 10.1016/s0165-5876(97)00176-6

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  6 in total

1.  Hearing loss in patients with mucopolysaccharidosis II: data from HOS - the Hunter Outcome Survey.

Authors:  Annerose Keilmann; Todsaporn Nakarat; Iain A Bruce; David Molter; Gunilla Malm
Journal:  J Inherit Metab Dis       Date:  2011-08-25       Impact factor: 4.982

2.  Age-related functional and histopathological changes of the ear in the MPS I mouse.

Authors:  Patricia A Schachern; Sebahattin Cureoglu; Vladimir Tsuprun; Michael M Paparella; Chester B Whitley
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2006-11-13       Impact factor: 1.675

3.  Vacuolization and alterations of lysosomal membrane proteins in cochlear marginal cells contribute to hearing loss in neuraminidase 1-deficient mice.

Authors:  Xudong Wu; Katherine A Steigelman; Erik Bonten; Huimin Hu; Wenxuan He; Tianying Ren; Jian Zuo; Alessandra d'Azzo
Journal:  Biochim Biophys Acta       Date:  2009-10-24

4.  Hearing loss in Pompe disease revisited: results from a study of 24 children.

Authors:  Carine I van Capelle; Andre Goedegebure; Nienke C Homans; Hans L J Hoeve; Arnold J Reuser; Ans T van der Ploeg
Journal:  J Inherit Metab Dis       Date:  2010-07-02       Impact factor: 4.982

5.  Hearing in adults with Pompe disease.

Authors:  Nadine A M E van der Beek; Hans Verschuure; Arnold J J Reuser; Ans T van der Ploeg; Pieter A van Doorn; René M L Poublon
Journal:  J Inherit Metab Dis       Date:  2011-10-15       Impact factor: 4.982

6.  The impact of laronidase treatment in otolaryngological manifestations of patients with mucopolysaccharidosis.

Authors:  Ana Paula Fiuza Funicello Dualibi; Ana Maria Martins; Gustavo Antônio Moreira; Marisa Frasson de Azevedo; Reginaldo Raimundo Fujita; Shirley Shizue Nagata Pignatari
Journal:  Braz J Otorhinolaryngol       Date:  2015-12-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.